EMA confirms recommendation for non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
Medical devices: new guidance for industry and notified bodies
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746)
Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations ((EU) 2017/745 and (EU) 2017/746) - tracked changes
CTIS newsflash - 17 May 2024
Agenda of the CVMP meeting 21-23 May 2024
Agenda of the COMP meeting 21-23 May 2024
Have your say and help shape EMA’s future communications
European medicines network designated as WHO listed authority
Minimum inhibitory concentration (MIC) breakpoints